Sade Martin, OTR | |
11311 Sw 95th Cir, Ocala, FL 34481-5064 | |
(540) 429-9227 | |
Not Available |
Full Name | Sade Martin |
---|---|
Gender | Female |
Speciality | |
Experience | Years |
Location | 11311 Sw 95th Cir, Ocala, Florida |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1205504073 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
225X00000X | Occupational Therapist | 22269 (Florida) | Primary |
Mailing Address | Practice Location Address |
---|---|
Sade Martin, OTR 524 Bahia Circle Trak, Ocala, FL 34472-8815 Ph: (540) 429-9227 | Sade Martin, OTR 11311 Sw 95th Cir, Ocala, FL 34481-5064 Ph: (540) 429-9227 |
News Archive
Why does sleeping on it help? This is the question tackled by new research at the University of Bristol, which reveals how brain activity during sleep sorts through the huge number of experiences we encounter every day, filing only the important information in memory.
SOME victims of serious illness experience much less pain than other sufferers, thanks to a natural biochemical variation in the cells of their bodies. Now a scientist at the University of Huddersfield has been awarded research funding that will aid his project to learn more about this variation and therefore develop treatments that could lead to the relief of pain for all patients, with much less dependence on drugs that can have distressing side effects.
Malaria kills a child every minute. While medical researchers have successfully developed effective drugs to kill the malaria parasite, efforts to treat the effects of the disease have not been as successful. But that soon may change.
RXi Pharmaceuticals Corporation, a biotechnology company focused on discovering, developing and commercializing innovative therapies addressing major unmet medical needs using RNA-targeted technologies, today announced positive results from their second placebo-controlled Phase 1 study with RXI‑109, an sd-rxRNA compound that targets Connective Tissue Growth Factor, and is being developed for the treatment of abnormal dermal scars such as hypertrophic scars and keloids in conjunction with scar revision surgery.
› Verified 6 days ago
Ivelisse M Cruz-lopez, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1501 Se 24th Rd, Ocala, FL 34471 Phone: 352-629-8900 | |
Kaitlyn M Littlejohn-oram, OT Occupational Therapist Medicare: Medicare Enrolled Practice Location: 2300 Se 17th St Ste 500, Ocala, FL 34471 Phone: 352-867-0444 | |
Sarah Leppert, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2620 Se Maricamp Rd, Ocala, FL 34471 Phone: 352-732-8883 Fax: 352-351-4219 | |
James M Sparkman, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 4511 Sw 48th Ave, Ocala, FL 34474 Phone: 866-236-1808 Fax: 866-236-1808 | |
Talalai's Occupational Therapy Services, Llc Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 3929 Sw 106th Pl, Ocala, FL 34476 Phone: 732-742-9840 | |
Anya Klumpp, OTD/OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 3019 Sw 27th Ave Ste 202, Ocala, FL 34471 Phone: 352-275-5778 | |
Lisa Marlene Thompson-goertz, OTR/L Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 9280 Sw 81st Ct, Ocala, FL 34481 Phone: 352-509-5201 |